Efficacy of Premedication Protocol without Ranitidine for Taxane Regimen: A Multicenter Non-Randomized Historical Controlled Study
CONCLUSION: The results of the study comprised evidence-based medicine supporting the safety of omitting ranitidine from the premedication protocol for the patients who had a taxane regimen and had a similar rate of HSRs to the use of ranitidine.PMID:35485693 | DOI:10.31557/APJCP.2022.23.4.1331
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Authors: Chaichana Chantharakhit Tanarat Ruchakorn Somprattana Mungkornkaew Pichyanin Amorntrakoon Siwadonn Tassanamethee Pathra Theeratrakul Nantapa Sujaritvanichpong Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | History of Medicine | Ranitidine | Statistics | Study